CL
OMIC

CRCM LP’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

CRCM LP’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-101,100
Closed -$1.58M – 7
2024
Q3 		$1.58M Buy
+101,100
New +$898K 1.03% 3

Other funds holding OMIC

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $76.6M AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CRCM LP's OMIC Position: Q4 2024 in Review

CRCM LP sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2024, closing a stake of 101,100 shares — an estimated $1.58M sold.

CRCM LP first reported a position in OMIC in Q3 2024 and held it in 1 quarter. The position peaked at $1.58M in Q3 2024. 20 funds tracked by Wall St. Rank hold OMIC as of Q4 2024.

  • CRCM LP reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • CRCM LP sold 101,100 Singular Genomics Systems, Inc. Common Stock shares in Q4 2024, an estimated $1.58M.
  • CRCM LP first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
  • CRCM LP's Singular Genomics Systems, Inc. Common Stock position peaked at $1.58M in Q3 2024.
  • 20 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2024.

Based on CRCM LP's 13F filing for Q4 2024, filed 7 Feb 2025.